Biotech · Private company
Shanghai EpimAb Biotherapeutics Co., Ltd.
Track this companyFree. Adds Shanghai EpimAb Biotherapeutics Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- EMB-01Phase 2 · Metastatic Lung Non-Small Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- EMB-01Phase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- EMB-02Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- OsimertinibPhase 2 · Metastatic Lung Non-Small Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerPHASE1_PHASE2 · UNKNOWN · started Jun 1, 2023ClinicalTrials.gov NCT05498389 · fetched Nov 12, 2026
- EMB-01 in Patients With Advanced/Metastatic Gastrointestinal CancersPHASE1_PHASE2 · UNKNOWN · started Oct 21, 2021ClinicalTrials.gov NCT05176665 · fetched Nov 12, 2026
- A Study of EMB-02 in Participants With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Mar 11, 2021ClinicalTrials.gov NCT04618393 · fetched Nov 12, 2026
- A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · UNKNOWN · started Dec 13, 2018ClinicalTrials.gov NCT03797391 · fetched Nov 12, 2026